News & Media
These press releases are intended as reference information for U.S. investors and journalists. The information contained in each press release was current at the time of issuance, and KCI assumes no responsibility for updating the information to reflect subsequent developments.
Seven new products now available from the TIELLE™ Foam Dressing Family complement extensive therapeutic options for chronic and acute wounds
Acelity Acquires SNaP® Disposable Negative Pressure Wound Therapy System to Expand Offering in Portable, Non-Powered NPWT Technology
Acquisition accelerates Acelity’s strategy in the disposable negative pressure wound therapy market
ACELITY and Mediq Partner to Strengthen Offering in Europe
Exclusive partnership will expand access to ACELITY’s advanced wound care and regenerative medicine portfolio for patients and clinicians in the Nordic Region
Acelity Announces Proposed Private Offering of $400 Million of First Lien Senior Secured Notes
ACELITY L.P. INC. REPORTS FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS FOR 2015
Total Revenue for the Fourth Quarter and Full Year of 2015 Grows 3.4% and 4.0%, respectively, on a Constant Currency Basis
Acelity Increases Focus on Growth, Expansion Opportunities
Appoints Dennis Crowley as Senior Vice President, Strategy, Business Development and Licensing
Acelity Expands TIELLE™ Advanced Foam Dressing Portfolio in Europe
TIELLE Silicone Border combines proven absorption technology with a soft silicone adhesive; provides clinicians a new option to minimize pain and trauma for patients living with wounds
ACELITY L.P. INC. REPORTS THIRD QUARTER AND FIRST NINE MONTHS FINANCIAL RESULTS FOR 2015
Total Revenue Grew 3.3% on a Constant Currency Basis
Acelity Announces Availability of Strattice™ Reconstructive Tissue Matrix (TM) Perforated for U.S.
New feature combines the proven regenerative performance of Strattice™ Tissue Matrix with added perforation to provide surgeons additional solutions for complex abdominal wall reconstruction
Acelity Deepens Commitment to Medical Education with Launch of Centres of Expertise Program in Europe
Acelity Announces Expansion of Prevena™ Therapy Portfolio with Addition of Shorter Peel & Place™ System
Acelity Advances Platform to Foster Innovation in Wound Care
“North America Make Better Summit”unites healthcare innovators from the United States and Canada in order to deliver better outcomes
Acelity Partners with GHD to Expand Access to Advanced Wound Dressing Portfolio in Germany
Partnership increases Acelity’s Footprint in German Market
Acelity L.P. Inc. Reports Second Quarter and First Half Financial Results for 2015
U.S. Advanced Wound Therapeutics revenue grew 10%
Acelity Receives National Blanket Purchase Agreement to Supply Advanced Wound Therapy for the Department of Veterans Affairs Facilities
Published Literature Review Demonstrates Promise of V.A.C. VeraFlo™ Therapy in Wound Treatment
Study Shows Use of Prevena™ Incision Management System on Cesarean Incisions Significantly Decreased Infectious Morbidity
Acelity Provides Support for The Plastic Surgery Foundation’s GRAFT Registry, the First Nationwide Fat Grafting Registry in U.S.
GRAFT Registry will Evaluate Fat Grafting for Aesthetic and Reconstructive Procedures in order to Provide Data for the Evaluation and Analysis of Patient Outcomes and Satisfaction Rates
REVOLVE™ Fat Grafting System by Acelity Now Available in Europe
REVOLVE™ System offers speed, quality, and reliability in high-volume fat transfer procedures
Acelity Supports Education and Development of Early-Stage Surgeons
More than 350 Delegates Attend Acelity Surgical Wound Forum in Prague
New Study Demonstrates Reduced Costs and Hospital Readmissions for Patients Treated with Acelity’s V.A.C.® Therapy vs. Alternative NPWT
Acelity L.P. Inc. Appoints Two New Members to its Board of Directors
Acelity L.P. Inc. Appoints Two New Members to its Board of Directors
LifeCell Obtains Preliminary Injunction Preventing TELA Bio
LifeCell Obtains Preliminary Injunction Preventing TELA Bio’s Launch of Its TELAMax Hernia Mesh
TIELLE® Non Adhesive Foam Dressing Now Available from Acelity
Innovative design provides superior wound exudate absorption to better meet patient needs
Nanova™ Therapy System Now Available from Acelity
Device Combines Absorbent Dressing with Negative Pressure Facilitates Earlier Patient Discharge
Acelity Streamlines Patient Care with Launch of iOn Healing™ Mobile App
New platform provides clinicians with direct access to Acelity solutions
Acelity Celebrates 20 Years of Transformational Wound Care Technology at Symposium of Advanced Wound Care
Acelity L.P. Inc. Reports First Quarter Financial Results for 2015
U.S. Advanced Wound Therapeutics revenue grew 11.0%
Acelity and Joerns RecoverCare Combine Strengths to Bring Efficiencies, Reduce Cost for Skilled Nursing Care
New Study Comparing ABThera™ to BVPT, Published in the Annals of Surgery, Demonstrated Reduced 90-Day Mortality
Acelity L.P. Inc. Reports Fourth Quarter and Full Year Financial Results for 2014
- Fourth quarter revenue grew 6.5% compared to the prior-year period, on a constant currency basis
- Fourth quarter 2014 Adjusted EBITDAfrom continuing operations1 grew 5.4% compared to the prior-year period, on a constant currency basis
- Fourth quarter loss from continuing operations was $30.9 million compared to $52.0 million for the prioryear period
Study Shows Positive Clinical and Potential Economic Outcomes with V.A.C. VeraFlo™ Therapy vs Standard V.A.C.® Therapy
Statistically Significant Reduction in Operating Room Debridements, Length of Therapy
Breast Reconstruction options featured on Lifetime® TV’s The Balancing Act
Acelity advocates for better treatment outcomes with “Know Your Breast Reconstruction Options”
Acelity Appoints Greg Kayata Senior Vice President, Human Resources
KCI Partners with B. Braun Medical to Sell Prontosan® Wound Irrigation Solution for Use with V.A.C. VeraFlo™ Negative Pressure Wound Therapy
Combination demonstrated a reduction in OR visits, length of stay and time to final surgical closure in recently published study
KCI, LifeCell and Systagenix Combine to Form One Company and Rebrand as Acelity
Acelity is Industry Leading Medical Technology Company with $2 Billion in Revenue
Centaur Announces CFO Transition Plan
CelluTome™ Epidermal Harvesting System Makes Podiatry Today’s Top 10 New Innovation List
New Study Reported Prevena™ Therapy Patients had a Significantly Lower Infection Rate Following Cardiac Surgery Compared to Control Group
Surgical incision management could generate savings of more than 60 million Euros in Germany alone
Independent Study Shows V.A.C. VeraFlo™ Therapy More Beneficial Than Traditional V.A.C.® Therapy
Study Found Statistically Significant Reductions in OR Visits and Hospital Stay vs. Traditional V.A.C.® Therapy
LifeCell Corporation Acquires Advanced Adipose Tissue Injector
Injector Offers Added Benefits to Surgeons and Patients and Expands the LifeCell Fat Grafting Portfolio
KCI Earns New Innovative Technology Designation from Novation® for V.A.C.Ulta™ Therapy and Prevena™ Therapy
Significant designation only provided to a small portion of products on contract through Novation
KCI Negative Pressure Wound Therapy with Instillation Supplement Published in International Wound Journal
Supplement Based on Presentations from the 2012 and 2013 International Surgical Wound Forums
First International Consensus Guidelines Published for KCI Negative Pressure Wound Therapy with Instillation
Guidelines Published in Journal of Plastic and Reconstructive Surgery
KCI Introduces the Next Generation V.A.C.Via™ Therapy System
Portable System Provides Enhanced Features for Patients
Growing Body of Evidence Supports V.A.C. VeraFlo™ Therapy Changing How Clinicians Approach Treating Wounds
Data Demonstrate Clinical and Economic Advantages of V.A.C. VeraFlo™ Therapy Compared to Traditional NPWT
KCI Completes Acquisition of Systagenix
Peter Huntley Appointed Senior Vice President and Leader of Systagenix
KCI, LifeCell and Systagenix to Form One Company Focused on Transformational Healing Solutions under the Leadership of President & CEO Joe Woody
ABThera™ Open Abdomen Negative Pressure Therapy System Study Published in World Journal of Surgery
Significantly Improved Patient Outcomes Using ABThera™ Negative Pressure Therapy System in Open Abdomen Surgery
KCI Introduces New V.A.C. VeraFlo™ Large Dressing
Taking Away the Large Burden of Wound Healing
KCI to Acquire Systagenix
Strategic Transaction Strengthens KCI Leadership Position in Global Wound Care Market While Adding Diversification
Enhances Access to $3.4 Billion Advanced Wound Care Market, Leveraging KCI’s Well-Established Customer Relationships, Brand and Commercial Scale
Complementary Product Portfolio Will Advance Provision of Best-in-Class Solutions to Healthcare Professionals and Patients
KCI Launches Novel Tool to Simplify Epidermal Harvesting
CelluTome™ Epidermal Harvesting System makes harvesting and subsequent grafting of epidermis accessible to more clinicians and patients
KCI Initiates Negative Pressure Wound Therapy with Instillation Randomized, Controlled Prospective Study
Study to Compare Traditional Negative Pressure Wound Therapy to V.A.C. VeraFlo™ Instillation Therapy, using the V.A.C.Ulta™ Negative Pressure Wound Therapy System
James G. Carlson Selected to Join Board of Directors
KCI Launches Prevena™ Peel & Place™ Dressing with V.A.C.® Therapy Connector
Benefits of surgical incision management now available to more patients
New Study Reports Key Findings for the ABThera™ Open Abdomen Negative Pressure Therapy System
Observational Study Showed Significantly Improved Patient Outcomes When the ABThera™ Negative Pressure Therapy System was Used in Open Abdomen Surgery
Independent Study Showed Decrease in Operating Room Visits for Patients with Infected Wounds using Adjunctive V.A.C. VeraFlo™ Therapy
Trend to Reduction in Hospital Stay vs. Traditional Negative Pressure Wound Therapy
KCI Announces Global Rollout of Novel Skin Graft Harvesting Tool
US Wound Care Physicians Introduced to CelluTome™ Epidermal Harvesting System
KCI Brings Enhanced Negative Pressure Wound Therapy System to Japan
Patients in Japan to Benefit from Innovative, Lightweight and Portable ActiV.A.C.® Therapy System
New Retrospective Study Reports Greater Effectiveness of KCI ABThera™ System Compared to Traditional Technique
Authors Conclude Significantly Greater Success with Ultimate Closure after Open Abdomen Management Compared to Barker Vacuum Pack Technique
Graftjacket® Regenerative Tissue Matrix Receives Medicare Reimbursement in Ten Northwestern States
Approximately 3.7 Million People Gain Access to Effective Treatment Option for Diabetic Foot Ulcers
Study Demonstrates Decreased Incidence of Groin Surgical Site Infection with Prevena™ Incision Management System
Study published in the Journal of Vascular Surgery
KCI Acquires New Skin Grafting Technology
KCI Announces the Completion of its Acquisition of MoMelan Technologies, Inc.
KCI Announces New Board Member
Timothy E. Guertin Selected to Join Board of Directors
KCI Announces New Prevena™ Incision Management System Study
Study Shows Positive Results for Prevena™ Incision Management System in Management of Closed Surgical Incisions for Obese Patients.
KCI Introduces Canadian Clinicians to the Next Evolution in V.A.C.® Therapy Technology
V.A.C.Ulta™ Negative Pressure Wound Therapy System Combines Proven V.A.C.® Therapy with New V.A.C. VeraFlo™ Therapy to Cleanse, Treat and Heal Wounds
KCI Sells Therapeutic Support Systems Business
Sale finalized November 8th to Getinge AB
KCI Responds to Hurricane Sandy
Information for Customers and Patients affected by Hurricane Sandy
KCI Expands Operations in Brazil
Global Leader in Wound Management will Provide Specialist Training to Local Healthcare Professionals to Improve Patient Outcomes
KCI Launches New Microclimate Product to Help Prevent and Treat Pressure Ulcers in Obese Patients
Skin IQ™ 1000 Microclimate Manager Offers Alternative to Conventional, Low Air Loss Therapy Mattresses
KCI Leads Educational Effort to Improve Patient Care Worldwide
World Union of Wound Healing Societies Commitment Includes Access to Review Articles on Recent Evolution of Negative Pressure Wound Therapy
KCI Agrees to Divest its Therapeutic Support Systems™ Business to Getinge AB
Kinetic Concepts, Inc. announced that it has signed a definitive agreement to sell its Therapeutic Support Systems™ business to Getinge AB.
Mike Mathews Named Senior Vice President, International at KCI
Mathews to Lead Commercial Business Activities in International Markets
Evidence Grows in Support of Prevena™ Incision Management System to Manage Closed Surgical Incisions
Results from clinical study demonstrated a significant patient benefit in using Prevena™ Therapy on this patient population.
KCI Announces FDA 510(k) Clearance of V.A.C.® Therapy for Management of Closed Surgical Incisions
Kinetic Concepts, Inc. announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) to market its proprietary Vacuum Assisted Closure®, or V.A.C.® Therapy System, for the management of closed surgical incisions.
Peter Arnold Named Senior Vice President of Innovation and Strategic Marketing at KCI
Kinetic Concepts, Inc. announced today that Peter Arnold has been named Senior Vice President of Innovation and Strategic Marketing.
Jim Cunniff Named Senior Vice President, Leading Commercial Activities in the Americas for KCI
Kinetic Concepts, Inc. announced today that James (Jim) Cunniff has been named Senior Vice President of the Americas.
The KCI Graftjacket® Regenerative Tissue Matrix Reimbursed by Medicare in Eight Midwestern States
Approximately 7.5 Million People Gain Access to Proven Safe, Effective Treatment Option for Diabetic Foot Ulcers
Abstract Published in Canadian Journal of Surgery Reports Key Preliminary Findings of Major Prospective Study of the KCI ABThera™ Open Abdomen Negative Pressure Therapy System
Kinetic Concepts, Inc. announced today that an abstract referring specifically to the KCI ABThera™ Open Abdomen Negative Pressure Therapy System (ABThera™ OA NPT), states that this "prospective cohort study observed a reduction in mortality (RR 0.48, 95% CI 0.25-0.92) and an increased fascial closure rate (RR 1.5, 95% CI 1.1 – 2.0) in patients who received the ABThera™ versus [Barker's technique] vacuum pack."
Joseph F. Woody and Lisa N. Colleran to Join Board of Directors of Parent Company of KCI and LifeCell
The parent company of Kinetic Concepts, Inc. (KCI) and LifeCell Corporation today announced that Joseph F. "Joe" Woody and Lisa N. Colleran will join the parent company's board of directors. Additionally, Ronald A. Matricaria has stepped down from the board as of March 31.
KCI Chosen as Single Source Supplier of Negative Pressure Wound Therapy Products Now Available to More than 65,000 Members and Affiliates Served by Novation
KCI Awarded Three-Year, Single Source Contract by Novation for NPWT Products
KCI Announces New Management Structure
The Board of Directors of the parent company of Kinetic Concepts, Inc. and LifeCell Corporation today announced that Ronald A. Matricaria has joined the Board of Directors and will serve as its Chairman.
KCI Supports CHRISTUS Santa Rosa Children’s Hospital Foundation with $20,000 Gift through Cards for Kids Program
KCI today announced a $20,000 gift to CHRISTUS Santa Rosa Children's Hospital Foundation to support many of the hospital's multidisciplinary programs for young patients in San Antonio and South Central Texas.
Joe Woody Named Global President of KCI's Active Healing Solutions™ Business
Kinetic Concepts , Inc. today announced the selection of Joseph (Joe) Woody as Global President of Active Healing Solutions™ (AHS), the company's advanced wound healing business. Woody is expected to join the KCI team in late November.
Kinetic Concepts, Inc. Gives Notice of Make-Whole Fundamental Change Conversion Rights to Holders of Its 3.25% Convertible Senior Notes due 2015
Reference is hereby made to the Indenture, dated as of April 21, 2008 (the "Indenture"), by and among Kinetic Concepts, Inc. (the "Company"), KCI USA, Inc., and U.S. Bank National Association, as trustee (in such capacity, the "Trustee"), relating to the Company's 3.25% Convertible Senior Notes due 2015 (CUSIP No. 49460WAF6) (the "Notes").
Kinetic Concepts, Inc. Completes Merger with Apax Consortium
Kinetic Concepts, Inc. (NYSE: KCI) today announced the completion of its acquisition by an affiliate of a consortium comprised of investment funds advised by Apax Partners
Kinetic Concepts, Inc. Gives Notice of Make-Whole Fundamental Change to Holders of Its 3.25% Convertible Senior Notes due 2015
Kinetic Concepts, Inc. (NYSE: KCI) today provided notice to holders of its 3.25 percent Convertible Senior Notes due 2015.
KCI and Consortium Led by Apax Partners Announce Completion of Executive Management Discussions
Kinetic Concepts, Inc. Shareholders Approve Merger Agreement
Two Leading Independent Proxy Advisory Firms Join ISS in Endorsing KCI Merger with Consortium Led by Apax Partners
Transaction Has Now Been Endorsed by Three of Nation's Top Proxy Advisory Firms
Leading Independent Proxy Advisory Firm ISS Recommends KCI Shareholders Vote 'FOR' Proposed Merger with Consortium Led by Apax Partners
Merger also receives all required regulatory approvals
KCI Announces Proposed Offering of Senior Notes
KCI Announces Special Meeting of Shareholders to Vote on Merger Agreement with Consortium Led by Apax Partners
Meeting Scheduled for October 28, 2011
KCI’s V.A.C.Via™ Therapy System Named a Leading Innovation by Podiatry Today
KCI today announced that its V.A.C.Via™ Therapy System was named one of the "Top Ten Innovations in Podiatric Technology" by trade publication Podiatry Today.
KCI Responds to Hurricane Irene
Information for Customers and Patients affected by Hurricane Irene
KCI Announces Agreement to Be Acquired by Consortium Including Apax Partners, CPPIB and PSP Investments in Transaction Valued at $6.3 Billion
KCI Shareholders to receive $68.50 per share in cash
Kinetic Concepts, Inc. Announces Date of Its Second Quarter 2011 Earnings Release and Conference Call
KCI's V.A.C.Via™ Therapy System to be Listed on U.K. Drug Tariff
V.A.C.Via™ System Has the Potential to Save National Health Service Money; Provides Benefits to Patients and Clinicians
KCI Awarded the Maximum Regional Contracts for NPWT in Germany
Facilitates Improved Patient Care and Access; Positions KCI as a Leader in the Region
Academy of Wound Technology and KCI Announce Launch of Transcontinental Wound Registry
Registry to Provide Clearer Insights Into Economic and Clinical Outcomes; Set to Debut at 2012 WUWHS Congress
Over $1 Million in KCI Wound Care Equipment Arrives in Joplin, Mo. To Aid Tornado Victims
Donation Helps Area Health Care Providers Treat Those Injured in the Disaster
KCI's TSS Business Unit Announces First Non-Foam-Based Pressure Redistribution Surface Available in U.S. for Patients up to 1000 Pounds
AtmosAir™ Fit MRS Sets a New Benchmark in the Challenge to Ensure Skin Integrity and Pressure Ulcer Prevention for Morbidly Obese Patients
Kinetic Concepts, Inc. Announces Plans to Declassify Its Board of Directors
Kinetic Concepts, Inc. announced today that the Board of Directors of KCI has determined that it will amend KCI's By-Laws prior to the 2012 annual meeting of shareholders to declassify the Board of Directors.
Kinetic Concepts, Inc. to Present at the 2011 Bank of America Merrill Lynch Healthcare Conference
KCI Names John Bibb as General Counsel
Kinetic Concepts, Inc. announced today that John Bibb has been promoted to general counsel for the company.
Kinetic Concepts, Inc. Announces Date of Its First Quarter 2011 Earnings Release and Conference Call
KCI Announces Plans for New Global Headquarters To Accommodate Growth, Expansion
Kinetic Concepts, Inc., a global leader in healing and regeneration, today announced plans for and broke ground on a new global headquarters in San Antonio.
KCI pledges $200,000 for Japan Relief
Company Also Ready to Donate Medical Equipment As Needed
Kinetic Concepts, Inc. to Present at the 2011 Canaccord Musculoskeletal Conference
KCI Licenses Wright Medical’s GRAFTJACKET® Brand for Wound Care
Deal Enables Full Commercialization of Regenerative Tissue Matrix Technology for Wound Care Patients, Including Those with Diabetic Foot Ulcers
KCI V.A.C.® GranuFoam™ Bridge XG Dressing Aids in the Treatment of Pressure Ulcers
Pressure Ulcers that can benefit from NPWT represent $1 Billion Market Opportunity in the U.S.
Kinetic Concepts, Inc. Announces Date of Its Fourth Quarter and Year-End 2010 Earnings Release and Conference Call
KCI to Expand Product Portfolio Through Acquisition of TechniMotion™ Patient Handling Technologies
Kinetic Concepts, Inc. announced the acquisition of substantially all of the assets and intellectual property of TechniMotion Medical, an Austin, Texas-based company that designs and develops innovative and ergonomic patient handling systems for acute and post-acute patient care.
Kinetic Concepts, Inc. to Present at the 29th Annual J.P. Morgan Healthcare Conference
Validity of KCI Patents Upheld in United Kingdom
Smith & Nephew's NPWT Products Found To Infringe
New therapeutic surface from KCI enhances skin integrity for the prevention and management of pressure ulcers
Skin IQ™ Microclimate Manager Helps Reduce Skin Moisture, Temperature, Friction and Shear
District Court Decision Received in NPWT Patent Litigation
The U.S. District Court for the Western District of Texas has issued a decision in the patent litigation between Kinetic Concepts, Inc. (NYSE:KCI), Wake Forest University and Smith & Nephew, Inc.
New KCI Product Designed to Manage Incisions Following Surgery, Such as General, OB/GYN, Orthopedic, Cardiac Procedures
Prevena™ Incision Management System now available to all U.S. hospitals
KCI Obtains Favorable Ruling in German Patent Case
Court Finds Smith & Nephew's Renasys EZ Product Infringes KCI Patent; Issues Injunction
KCI Obtains Injunction against Smith & Nephew in United Kingdom
UK High Court of Justice Enters Injunction Against Smith & Nephew’s NPWT Products; Injunction Stayed Pending Expedited Appeal
KCI Boosts Research and Development Capabilities with Launch of Advanced Research and Technology Center
Innovation Center to Accelerate Company Mission of Making Healing Possible; New Organization Will Fuel Product Development and Commercialization
KCI Renews Single-Source Contracts with Novation for Therapeutic Support Systems
KCI to Continue as Supplier for More Than 30,500 U.S. Health Care Facilities Affiliated with VHA Inc., University HealthSystem Consortium (UHC) and Provista, LLC
KCI Wins UK Patent Case Against Smith & Nephew
UK High Court of Justice Finds Smith & Nephew's Products Infringe Two NPWT Patents Exclusively Owned By KCI
KCI Prevena™ Incision Management System Licensed by Health Canada
Designed to Help Manage Patients' Incisions Successfully Following Surgery
KCI Receives FDA Clearance for Prevena™ Incision Management System
Postsurgical Incision Management Represents $1 Billion Global Market Opportunity: U.S. Approval Follows Prevena™ System Launch in Europe and Canada
KCI First Manufacturer to Commit to Submitting Product Labeling for FDA Medical Device Home Use Initiative
Move Signals KCI's Support of FDA's Goal of Ensuring Strong Standards for Patient Home Use
KCI Announces FDA Clearance of V.A.C.® Therapy for Venous Insufficiency Ulcers
Extends KCI's Reach Across All Three Major Chronic Wound Types
International Consensus Document Offers Greater Clarity on Treatment and Prevention of Pressure Ulcers
New insights from global experts on pressure ulcers to be released at the 20th Conference of the European Wound Management Association (EWMA) in Geneva
KCI to Feature Full Range of Negative Pressure Technology Platform at EWMA
KCI will launch its full range of new NPTP products and support the release of a consensus document on pressure ulcer prevention titled International Review - Pressure, Shear, Friction and Microclimate in Context
KCI Appoints Ron Silverman, M.D., FACS, Chief Medical Officer
Latest Innovation Provides Groundbreaking Design in Negative Pressure Wound Therapy
KCI Statement on FDA Medical Device Home Use Initiative
KCI issued a statement today from Catherine Burzik, KCI president and CEO, regarding the U.S. Food and Drug Administration's (FDA) medical device home use initiative.
KCI to Launch the V.A.C.VIA™, an Advanced Mobile Healing Technology
Latest Innovation Provides Groundbreaking Design in Negative Pressure Wound Therapy
KCI Appoints Kien Nguyen Vice President of Global Marketing for Active Healing Solutions™
Will Oversee Global Market Development for Negative Pressure Technology Platform
KCI to Feature Unparalleled Range of NPTP Products and Services at SAWC
Negative Pressure Symposium and Conference Exhibit to Focus on KCI's Ongoing Commitment to Improve and Simplify Negative Pressure Treatments
KCI Announces First Patient Placement of V.A.C. Therapy in Japan
Launch of Innovative Therapy Represents First Step in Broader Product Introduction and Market Development Strategy
KCI Launches the Prevena™ Incision Management System in Europe and Canada
Prevena™ System First and Only Powered Negative Pressure Product Designed to Manage Incisions at Risk of Complication
KCI Wins Patent Case Against Smith & Nephew
United States District Court Jury Finds that Smith & Nephew’s Product Infringes Wake Forest Patents Licensed to KCI
KCI Announces Reimbursement Approval in Japan
Reimbursement Clears Way to Commercialize KCI’s Revolutionary V.A.C.® Therapy System in Japan
KCI Launches Rotoprone™ Therapy System Web Site Showcasing Strong Clinical Evidence
New Site, RotoProne.com, Dedicated to Clinician Education on Managing Patients with Severe Respiratory Distress
KCI First Commercial Entity to Receive Nursing Skills Competency Program™ Accreditation from American Nurses Credentialing Center
KCI Shows Commitment to Product Education by Accreditation through Nursing Skills Competency Program
KCI Pledges additional Haiti Relief
Disaster has a way of bringing us together. Today KCI has come together as a company to address the significant needs of the people in Haiti. As you know, KCI has been able to donate our products, and now we’d like to help stretch the impact of donations employees may choose to make to the Haiti relief efforts.
KCI Sends Critically Needed Medical Products to Haiti to Help Treat Seriously Wounded
KCI Donates its Signature V.A.C.® Therapy and Other Wound Care Products; In-Kind Donation Valued at More Than $2 Million
2009 Nursing Education Needs Assessment Survey
2009 Nursing Education Needs Assessment Survey
Analyst Day 2009
Click the link below to listen to KCI Analyst Day 2009 held 11/09/2009 in New York, NY 11/09/2009.
KCI Announces Final Approval to Enter Japan Market
Formal regulatory approval enables commercialization of innovative V.A.C.® Therapy System in Japan.
Kinetic Concepts Reports Financial Results for Third Quarter and First Nine Months of 2009
Kinetic Concepts, Inc. (NYSE: KCI) today reported third quarter 2009 total revenue of $504.4 million, compared to $503.3 million reported for the third quarter of 2008.
KCI honors Dr. Louis Argenta with research-based fellowship and scholarship
Grant celebrates the conception of Negative Pressure Wound Therapy
KCI Hosts Investigator Meeting for New Multicenter Observational ABTAC Study during American College of Surgeons' Clinical Congr
Hosts Open Abdomen Management Symposium Featuring Top Surgical, Critical Care Experts
Australian Appeals Court Lifts Temporary Injunction Against Smith & Nephew Foam Dressing Kit
Full Court of The Federal Court of Australia, Victoria District Registry has lifted a temporary injunction in KCI’s patent litigation with Smith & Nephew (LSE: SN, NYSE: SNN).
KCI Highlights ABThera™ Open Abdomen Negative Pressure Therapy System at American Association for the Surgery of Trauma Conference Symposium
Company Also Introduces New U.S. Open Abdomen Management System Clinical Guidelines
KCI Reunited with Formerly Conjoined Egyptian Twins after Landmark Surgery
Ahmed and Mohamed Ibrahim, the eight-year-old craniopagus twins successfully separated during a well-documented and risky 34-hour operation in 2003, will visit Kinetic Concepts Inc. (KCI) Friday for a celebratory reunion.
KCI Sponsors Georgetown Diabetic Limb Salvage Conference Symposium Featuring Top Limb Preservation Experts
Kinetic Concepts, Inc. (KCI) will sponsor a CME-accredited panel discussion, “The Role of NPWT in the Team Approach to Limb Salvage: Case Studies,” at the 3rd Annual Georgetown Diabetic Limb Salvage conference September 24-26.
KCI Announces Expected Regulatory Approval to Enter Japan Market
KCI announced today that it has been informed by the Pharmaceutical and Medical Devices Agency in Japan that in October the Ministry of Health, Labor and Welfare will grant regulatory approval for KCI to begin market development activities in Japan for its innovative V.A.C.® Therapy product.
Kinetic Concepts, Inc. to Participate in the Thomas Weisel Partners Healthcare Conference 2009
Kinetic Concepts, Inc. (NYSE:KCI) today announced that Catherine Burzik, President and Chief Executive Officer, will present at the Thomas Weisel Partners Healthcare Conference 2009 at the Four Seasons Hotel in Boston, Massachusetts.
KCI Launches Innovative ABThera(TM) Open Abdomen Negative Pressure Therapy System to Help Manage Patients with Severe Conditions
Kinetic Concepts, Inc. (NYSE: KCI), today announced the official launch of ABThera™ open abdomen negative pressure therapy system, the latest addition to its Negative Pressure Technology Platform (NPTP).
United States Patent and Trademark Office Confirms Validity of KCI Negative Pressure Wound Therapy Patents
Kinetic Concepts, Inc. (NYSE: KCI) today announced that the U.S. Patent and Trademark Office (USPTO) issued Office actions confirming the validity of three separate patents licensed to KCI by Wake Forest University Health Sciences in re-examination proceedings.
KCI Appoints Michael Genau to New Global Leadership Position That Directs Expansion of Current Wound Therapy Division
Kinetic Concepts, Inc. (NYSE: KCI) announced today that Michael Genau has joined the Company in the newly formed position of Global President, Wound Therapy.
KCI Announces Intention to Appeal UK Court Ruling Revoking NPWT Patent
Kinetic Concepts, Inc. (NYSE: KCI) announced today that the Court of Appeal of England and Wales has revoked a patent licensed to KCI from Wake Forest University.
Department of Health (DH) highlights V.A.C.(R) Therapy As Having High Potential in Improving Community-Based Wound Care
Improving wound care in the community may be the fastest route to reach some of Lord Darzi’s proposed quality improvements for the NHS. And using KCI’s V.A.C.®
Kinetic Concepts, Inc. Announces Date of its Second Quarter 2009 Earnings Release and Conference Call
Kinetic Concepts, Inc. (NYSE:KCI), today announced that it will report its second quarter 2009 financial results on Tuesday, July 21, 2009, at 6:00 a.m. EDT.
Australia Court Issues Temporary Injunction Prohibiting Smith & Nephew from Selling Negative Pressure Wound Therapy Foam Dressing Kit
Kinetic Concepts, Inc. (NYSE: KCI) announced today that The Federal Court of Australia, Victoria District Registry, issued a temporary injunction prohibiting Smith & Nephew (LSE: SN; NYSE: SNN) from selling foam dressing kits for negative pressure wound therapy in Australia until the court can rule on the patent infringement action brought against Smith & Nephew by KCI.
KCI and YHEC Launch Flexible New Evidence-based Tool to Help Hospitals Optimize Pressure Ulcer Treatment Strategies
Kinetic Concepts, Inc. in conjunction with The York Health Economics Consortium (YHEC) will launch a new Budget Impact Model (BIM) for wound care surfaces at the European Wound Management Association (EWMA) Conference in Helsinki .
KCI Announces European Launch of Innovative V.A.C. Simplace Dressing and V.A.C. GranuFoam Bridge Dressing Products
Kinetic Concepts, Inc. to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
KCI Issues Statement Regarding AHRQ Draft Report
KCI and Carroll Hospital Group Inc. Partner to Help Prevent Pressure Ulcers and Reduce Patient Falls
KCI Announces Plans to Optimize Operations
KCI Unveils Diabetic Foot Ulcer Campaign
KCI Introduces new V.A.C. GranuFoam Bridge Dressing
KCI announced today the U.S. market launch of its new V.A.C.® GranuFoam™ Bridge Dressing, further expanding the portfolio of dressings used in the treatment of chronic wounds. This new dressing is expected to simplify application in chronic wounds, especially Diabetic Foot Ulcers (DFUs) where it is compatible with off-loading devices.
International Pressure Ulcer Experts Present Guidelines for Performing Prevalence and Incidence Studies
KCI Announces Court of Appeals Affirms Lower Court Ruling
KCI 2008 Earnings Release
KCI Obtains Temporary Injunction in the United Kingdom Against Smith & Nephew Foam Dressing Kit
Kinetic Concepts, Inc. (NYSE:KCI) announced today that a temporary injunction against Smith & Nephew has been granted by the Specialist Patents Court in the High Court of Justice of England and Wales.
Kinetic Concepts, Inc. to Present at the 27th Annual JPMorgan Healthcare Conference
Kinetic Concepts, Inc. (NYSE:KCI) today announced that Catherine Burzik, President and Chief Executive Officer, will present at the 27th Annual JPMorgan Healthcare Conference in San Francisco.
KCI Files Patent Infringement Suit Against Convatec and Boehringer
KCI Introduces its New V.A.C. Simplace Dressing Featuring V.A.C. GranuFoam and 3M Tegaderm Dressings
KCI Files New Patent Infringement Claims Against Smith & Nephew
Kinetic Concepts, Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference
KCI Announces Agreement with 3M Health Care